Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel anti-CD19 chimeric antigen receptor (CAR) T cell therapy, obecabtagene ...

Highlights in acute lymphoblastic leukemia (ALL), presented at the American ... BLIN improved outcomes for children with standard-risk B-cell ALL (B-ALL) at average or higher risk for relapse.

Ryan, a 12-year-old Massapequa Park native, was diagnosed with B-cell acute lymphoblastic leukemia in August of 2024. It is a ...

2024 — Scientists have identified novel genetic variations that influence relapse risk in children with standard risk B-cell acute lymphoblastic leukemia (SR B-ALL), the most common childhood ...

The EC's decision was based on results from a Phase III trial of Blincyto with multiphase consolidation chemotherapy.

Hammer Down Cancer game featured player-worn jerseys auctioned off for cancer research, and coaches' shoes will be auctioned ...

Autolus Therapeutics (AUTL) announces an oral presentation and three poster presentations accepted to the 2025 Tandem Meetings ...